Skip to main content
Erschienen in: Current Allergy and Asthma Reports 4/2010

01.07.2010

Modern Approaches to the Diagnosis and Treatment of Cold Contact Urticaria

verfasst von: Karoline Krause, Torsten Zuberbier, Marcus Maurer

Erschienen in: Current Allergy and Asthma Reports | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Cold contact urticaria (CCU) is a common subtype of physical urticaria characterized by itchy wheals and/or angioedema due to skin mast cell activation and the release of proinflammatory mediators after cold exposure. The underlying causes are largely unknown. When CCU is suspected, cold stimulation tests and threshold testing should be done to confirm the diagnosis and to determine the severity and course of CCU, respectively. Avoidance of critical cold exposure should be recommended but is often impossible, especially for severely affected patients with high temperature and low exposure time thresholds. Symptomatic treatment of choice is the use of modern, nonsedating antihistamines. Patients should be informed that complete protection from CCU symptom development may require increased doses of antihistamines. Standardizing cold provocation tests and further characterization of the natural course of CCU and its variants may lead to a better understanding of the disease-driving mechanisms.
Literatur
1.
Zurück zum Zitat Siebenhaar F, Weller K, Mlynek A, et al.: Acquired cold urticaria: clinical picture and update on diagnosis and treatment. Clin Exp Dermatol 2007, 32:241–245.CrossRefPubMed Siebenhaar F, Weller K, Mlynek A, et al.: Acquired cold urticaria: clinical picture and update on diagnosis and treatment. Clin Exp Dermatol 2007, 32:241–245.CrossRefPubMed
2.
Zurück zum Zitat Magerl M, Borzova E, Gimenez-Arnau A, et al.: The definition and diagnostic testing of physical and cholinergic urticarias—EAACI/GALEN/EDF/UNEV consensus panel recommendations. Allergy 2009, 64:1715–1721.CrossRefPubMed Magerl M, Borzova E, Gimenez-Arnau A, et al.: The definition and diagnostic testing of physical and cholinergic urticarias—EAACI/GALEN/EDF/UNEV consensus panel recommendations. Allergy 2009, 64:1715–1721.CrossRefPubMed
3.
Zurück zum Zitat Zuberbier T, Asero R, Bindslev-Jensen C, et al.: EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009, 64:1417–1426.CrossRefPubMed Zuberbier T, Asero R, Bindslev-Jensen C, et al.: EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009, 64:1417–1426.CrossRefPubMed
4.
Zurück zum Zitat Wanderer AA, Grandel KE, Wasserman SI, Farr RS: Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. J Allergy Clin Immunol 1986, 78:417–423.CrossRefPubMed Wanderer AA, Grandel KE, Wasserman SI, Farr RS: Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. J Allergy Clin Immunol 1986, 78:417–423.CrossRefPubMed
5.
Zurück zum Zitat Neittaanmaki H: Cold urticaria. Clinical findings in 220 patients. J Am Acad Dermatol 1985, 13:636–644.CrossRefPubMed Neittaanmaki H: Cold urticaria. Clinical findings in 220 patients. J Am Acad Dermatol 1985, 13:636–644.CrossRefPubMed
6.
Zurück zum Zitat Alangari AA, Twarog FJ, Shih MC, Schneider LC: Clinical features and anaphylaxis in children with cold urticaria. Pediatrics 2004, 113:e313–e317.CrossRefPubMed Alangari AA, Twarog FJ, Shih MC, Schneider LC: Clinical features and anaphylaxis in children with cold urticaria. Pediatrics 2004, 113:e313–e317.CrossRefPubMed
7.
Zurück zum Zitat Katsarou-Katsari A, Makris M, Lagogianni E, et al.: Clinical features and natural history of acquired cold urticaria in a tertiary referral hospital: a 10-year prospective study. J Eur Acad Dermatol Venereol 2008, 22:1405–1411.CrossRefPubMed Katsarou-Katsari A, Makris M, Lagogianni E, et al.: Clinical features and natural history of acquired cold urticaria in a tertiary referral hospital: a 10-year prospective study. J Eur Acad Dermatol Venereol 2008, 22:1405–1411.CrossRefPubMed
8.
Zurück zum Zitat Mathelier-Fusade P, Aissaoui M, Bakhos D, et al.: Clinical predictive factors of severity in cold urticaria. Arch Dermatol 1998, 134:106–107.CrossRefPubMed Mathelier-Fusade P, Aissaoui M, Bakhos D, et al.: Clinical predictive factors of severity in cold urticaria. Arch Dermatol 1998, 134:106–107.CrossRefPubMed
9.
Zurück zum Zitat Moller A, Henning M, Zuberbier T, Czarnetzki-Henz BM: [Epidemiology and clinical aspects of cold urticaria]. Hautarzt 1996, 47:510–514.CrossRefPubMed Moller A, Henning M, Zuberbier T, Czarnetzki-Henz BM: [Epidemiology and clinical aspects of cold urticaria]. Hautarzt 1996, 47:510–514.CrossRefPubMed
10.
Zurück zum Zitat Murphy GF, Austen KF, Fonferko E, Sheffer AL: Morphologically distinctive forms of cutaneous mast cell degranulation induced by cold and mechanical stimuli: an ultrastructural study. J Allergy Clin Immunol 1987, 80:603–611.CrossRefPubMed Murphy GF, Austen KF, Fonferko E, Sheffer AL: Morphologically distinctive forms of cutaneous mast cell degranulation induced by cold and mechanical stimuli: an ultrastructural study. J Allergy Clin Immunol 1987, 80:603–611.CrossRefPubMed
11.
Zurück zum Zitat Kaplan AP, Beaven MA: In vivo studies of the pathogenesis of cold urticaria, cholinergic urticaria, and vibration-induced swelling. J Invest Dermatol 1976, 67:327–332.CrossRefPubMed Kaplan AP, Beaven MA: In vivo studies of the pathogenesis of cold urticaria, cholinergic urticaria, and vibration-induced swelling. J Invest Dermatol 1976, 67:327–332.CrossRefPubMed
12.
Zurück zum Zitat Wasserman SI, Soter NA, Center DM, Austen KF: Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge. J Clin Invest 1977, 60:189–196.CrossRefPubMed Wasserman SI, Soter NA, Center DM, Austen KF: Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge. J Clin Invest 1977, 60:189–196.CrossRefPubMed
13.
Zurück zum Zitat Grandel KE, Farr RS, Wanderer AA, et al.: Association of platelet-activating factor with primary acquired cold urticaria. N Engl J Med 1985, 313:405–409.PubMed Grandel KE, Farr RS, Wanderer AA, et al.: Association of platelet-activating factor with primary acquired cold urticaria. N Engl J Med 1985, 313:405–409.PubMed
14.
Zurück zum Zitat Ormerod AD, Kobza Black A, Dawes J, et al.: Prostaglandin D2 and histamine release in cold urticaria unaccompanied by evidence of platelet activation. J Allergy Clin Immunol 1988, 82:586–589.CrossRefPubMed Ormerod AD, Kobza Black A, Dawes J, et al.: Prostaglandin D2 and histamine release in cold urticaria unaccompanied by evidence of platelet activation. J Allergy Clin Immunol 1988, 82:586–589.CrossRefPubMed
15.
Zurück zum Zitat Tillie-Leblond I, Gosset P, Janin A, et al.: Tumor necrosis factor-alpha release during systemic reaction in cold urticaria. J Allergy Clin Immunol 1994, 93:501–509.CrossRefPubMed Tillie-Leblond I, Gosset P, Janin A, et al.: Tumor necrosis factor-alpha release during systemic reaction in cold urticaria. J Allergy Clin Immunol 1994, 93:501–509.CrossRefPubMed
16.
Zurück zum Zitat Kaplan AP, Garofalo J, Sigler R, Hauber T: Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies. N Engl J Med 1981, 305:1074–1077.PubMedCrossRef Kaplan AP, Garofalo J, Sigler R, Hauber T: Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies. N Engl J Med 1981, 305:1074–1077.PubMedCrossRef
17.
Zurück zum Zitat Koda H, Kanaide A, Asahi M, Urabe H: Essential IgG cryoglobulinemia with purpura and cold urticaria. Arch Dermatol 1978, 114:784–786.CrossRefPubMed Koda H, Kanaide A, Asahi M, Urabe H: Essential IgG cryoglobulinemia with purpura and cold urticaria. Arch Dermatol 1978, 114:784–786.CrossRefPubMed
18.
Zurück zum Zitat Doeglas HM, Rijnten WJ, Schroder FP, Schirm J: Cold urticaria and virus infections: a clinical and serological study in 39 patients. Br J Dermatol 1986, 114:311–318.CrossRefPubMed Doeglas HM, Rijnten WJ, Schroder FP, Schirm J: Cold urticaria and virus infections: a clinical and serological study in 39 patients. Br J Dermatol 1986, 114:311–318.CrossRefPubMed
19.
Zurück zum Zitat Miralles Lopez JC, Lopez Andreu FR, Sanchez-Gascon F, et al.: Cold urticaria associated with acute serologic toxoplasmosis. Allergol Immunopathol (Madr) 2005, 33:172–174.CrossRef Miralles Lopez JC, Lopez Andreu FR, Sanchez-Gascon F, et al.: Cold urticaria associated with acute serologic toxoplasmosis. Allergol Immunopathol (Madr) 2005, 33:172–174.CrossRef
20.
Zurück zum Zitat Kranke B, Mayr-Kanhauser S, Aberer W: Helicobacter pylori in acquired cold urticaria. Contact Dermatitis 2001, 44:57–58.CrossRefPubMed Kranke B, Mayr-Kanhauser S, Aberer W: Helicobacter pylori in acquired cold urticaria. Contact Dermatitis 2001, 44:57–58.CrossRefPubMed
21.
Zurück zum Zitat Kalogeromitros D, Gregoriou S, Papaioannou D, et al.: Acquired primary cold contact urticaria after Hymenoptera sting. Clin Exp Dermatol 2004, 29:93–95.CrossRefPubMed Kalogeromitros D, Gregoriou S, Papaioannou D, et al.: Acquired primary cold contact urticaria after Hymenoptera sting. Clin Exp Dermatol 2004, 29:93–95.CrossRefPubMed
22.
Zurück zum Zitat Mathelier-Fusade P, Leynadier F: Acquired cold urticaria after jellyfish sting. Contact Dermatitis 1993, 29:273.CrossRefPubMed Mathelier-Fusade P, Leynadier F: Acquired cold urticaria after jellyfish sting. Contact Dermatitis 1993, 29:273.CrossRefPubMed
23.
Zurück zum Zitat Kranke B, Mayr-Kanhauser S: Cold urticaria and angiotensin converting enzyme inhibitor. Acta Derm Venereol 2002, 82:149–150.CrossRefPubMed Kranke B, Mayr-Kanhauser S: Cold urticaria and angiotensin converting enzyme inhibitor. Acta Derm Venereol 2002, 82:149–150.CrossRefPubMed
24.
Zurück zum Zitat Wanderer AA, Hoffman HM: The spectrum of acquired and familial cold-induced urticaria/urticaria-like syndromes. Immunol Allergy Clin North Am 2004, 24:259–286, vii.CrossRefPubMed Wanderer AA, Hoffman HM: The spectrum of acquired and familial cold-induced urticaria/urticaria-like syndromes. Immunol Allergy Clin North Am 2004, 24:259–286, vii.CrossRefPubMed
25.
Zurück zum Zitat Siebenhaar F, Staubach P, Metz M, et al.: Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria. J Allergy Clin Immunol 2004, 114:1224–1225.CrossRefPubMed Siebenhaar F, Staubach P, Metz M, et al.: Peltier effect-based temperature challenge: an improved method for diagnosing cold urticaria. J Allergy Clin Immunol 2004, 114:1224–1225.CrossRefPubMed
26.
Zurück zum Zitat • Mlynek A, Magerl M, Siebenhaar F, et al.: Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria. Br J Dermatol 2009 Sep 28 (Epub ahead of print). This articles discusses the relevance of determining temperature thresholds in CCU patients in order to assess disease severity. • Mlynek A, Magerl M, Siebenhaar F, et al.: Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria. Br J Dermatol 2009 Sep 28 (Epub ahead of print). This articles discusses the relevance of determining temperature thresholds in CCU patients in order to assess disease severity.
27.
Zurück zum Zitat Kivity S, Schwartz Y, Wolf R, Topilsky M: Systemic cold-induced urticaria—clinical and laboratory characterization. J Allergy Clin Immunol 1990, 85:52–54.CrossRefPubMed Kivity S, Schwartz Y, Wolf R, Topilsky M: Systemic cold-induced urticaria—clinical and laboratory characterization. J Allergy Clin Immunol 1990, 85:52–54.CrossRefPubMed
28.
Zurück zum Zitat Kaplan AP: Unusual cold-induced disorders: cold-dependent dermatographism and systemic cold urticaria. J Allergy Clin Immunol 1984, 73:453–456.CrossRefPubMed Kaplan AP: Unusual cold-induced disorders: cold-dependent dermatographism and systemic cold urticaria. J Allergy Clin Immunol 1984, 73:453–456.CrossRefPubMed
29.
Zurück zum Zitat Kaplan AP, Garofalo J: Identification of a new physically induced urticaria: cold-induced cholinergic urticaria. J Allergy Clin Immunol 1981, 68:438–441.CrossRefPubMed Kaplan AP, Garofalo J: Identification of a new physically induced urticaria: cold-induced cholinergic urticaria. J Allergy Clin Immunol 1981, 68:438–441.CrossRefPubMed
30.
31.
Zurück zum Zitat Czarnetzki BM, Frosch PJ, Sprekeler R: Localized cold reflex urticaria. Br J Dermatol 1981, 104:83–87.CrossRefPubMed Czarnetzki BM, Frosch PJ, Sprekeler R: Localized cold reflex urticaria. Br J Dermatol 1981, 104:83–87.CrossRefPubMed
32.
Zurück zum Zitat Wanderer AA: Systemic cold urticaria (atypical acquired cold urticaria). J Allergy Clin Immunol 1991, 87:137–138.CrossRefPubMed Wanderer AA: Systemic cold urticaria (atypical acquired cold urticaria). J Allergy Clin Immunol 1991, 87:137–138.CrossRefPubMed
33.
Zurück zum Zitat Hoffman HM, Mueller JL, Broide DH, et al.: Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001, 29:301–305.CrossRefPubMed Hoffman HM, Mueller JL, Broide DH, et al.: Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001, 29:301–305.CrossRefPubMed
34.
Zurück zum Zitat Hoffman HM, Wanderer AA, Broide DH: Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol 2001, 108:615–620.CrossRefPubMed Hoffman HM, Wanderer AA, Broide DH: Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol 2001, 108:615–620.CrossRefPubMed
35.
Zurück zum Zitat Soter NA, Joshi NP, Twarog FJ, et al.: Delayed cold-induced urticaria: a dominantly inherited disorder. J Allergy Clin Immunol 1977, 59:294–297.CrossRefPubMed Soter NA, Joshi NP, Twarog FJ, et al.: Delayed cold-induced urticaria: a dominantly inherited disorder. J Allergy Clin Immunol 1977, 59:294–297.CrossRefPubMed
36.
Zurück zum Zitat Gandhi C, Healy C, Wanderer AA, Hoffman HM: Familial atypical cold urticaria: description of a new hereditary disease. J Allergy Clin Immunol 2009, 124:1245–1250.CrossRefPubMed Gandhi C, Healy C, Wanderer AA, Hoffman HM: Familial atypical cold urticaria: description of a new hereditary disease. J Allergy Clin Immunol 2009, 124:1245–1250.CrossRefPubMed
37.
Zurück zum Zitat Zuberbier T, Asero R, Bindslev-Jensen C, et al.: EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009, 64:1427–1443.CrossRefPubMed Zuberbier T, Asero R, Bindslev-Jensen C, et al.: EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009, 64:1427–1443.CrossRefPubMed
38.
Zurück zum Zitat Wanderer AA, Ellis EF: Treatment of cold urticaria with cyproheptadine. J Allergy Clin Immunol 1971, 48:366–371.CrossRefPubMed Wanderer AA, Ellis EF: Treatment of cold urticaria with cyproheptadine. J Allergy Clin Immunol 1971, 48:366–371.CrossRefPubMed
39.
Zurück zum Zitat Neittaanmaki H, Myohanen T, Fraki JE: Comparison of cinnarizine, cyproheptadine, doxepin, and hydroxyzine in treatment of idiopathic cold urticaria: usefulness of doxepin. J Am Acad Dermatol 1984, 11:483–489.CrossRefPubMed Neittaanmaki H, Myohanen T, Fraki JE: Comparison of cinnarizine, cyproheptadine, doxepin, and hydroxyzine in treatment of idiopathic cold urticaria: usefulness of doxepin. J Am Acad Dermatol 1984, 11:483–489.CrossRefPubMed
40.
Zurück zum Zitat Church MK, Maurer M, Simons FER, et al.: Should first-generation H1-antihistamines still be available as over-the-counter medications? A GA2LEN task force report. Allergy 2010 (in press). Church MK, Maurer M, Simons FER, et al.: Should first-generation H1-antihistamines still be available as over-the-counter medications? A GA2LEN task force report. Allergy 2010 (in press).
41.
Zurück zum Zitat Juhlin L, de Vos C, Rihoux JP: Inhibiting effect of cetirizine on histamine-induced and 48/80-induced wheals and flares, experimental dermographism, and cold-induced urticaria. J Allergy Clin Immunol 1987, 80:599–602.CrossRefPubMed Juhlin L, de Vos C, Rihoux JP: Inhibiting effect of cetirizine on histamine-induced and 48/80-induced wheals and flares, experimental dermographism, and cold-induced urticaria. J Allergy Clin Immunol 1987, 80:599–602.CrossRefPubMed
42.
Zurück zum Zitat Dubertret L, Pecquet C, Murrieta-Aguttes M, Leynadier F: Mizolastine in primary acquired cold urticaria. J Am Acad Dermatol 2003, 48:578–583.CrossRefPubMed Dubertret L, Pecquet C, Murrieta-Aguttes M, Leynadier F: Mizolastine in primary acquired cold urticaria. J Am Acad Dermatol 2003, 48:578–583.CrossRefPubMed
43.
Zurück zum Zitat Magerl M, Schmolke J, Siebenhaar F, et al.: Acquired cold urticaria symptoms can be safely prevented by ebastine. Allergy 2007, 62:1465–1468.CrossRefPubMed Magerl M, Schmolke J, Siebenhaar F, et al.: Acquired cold urticaria symptoms can be safely prevented by ebastine. Allergy 2007, 62:1465–1468.CrossRefPubMed
44.
Zurück zum Zitat •• Siebenhaar F, Degener F, Zuberbier T, et al.: High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol 2009, 123:672–679. The efficacy and safety of high-dose, nonsedating antihistamines in the reduction of clinical symptoms in CCU is shown in a placebo-controlled, randomized trial.CrossRefPubMed •• Siebenhaar F, Degener F, Zuberbier T, et al.: High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol 2009, 123:672–679. The efficacy and safety of high-dose, nonsedating antihistamines in the reduction of clinical symptoms in CCU is shown in a placebo-controlled, randomized trial.CrossRefPubMed
45.
Zurück zum Zitat Di Leo E, Nettis E, Cassano N, et al.: Treatment of acquired cold urticaria with rupatadine. Allergy 2009, 64:1387–1388.CrossRefPubMed Di Leo E, Nettis E, Cassano N, et al.: Treatment of acquired cold urticaria with rupatadine. Allergy 2009, 64:1387–1388.CrossRefPubMed
46.
Zurück zum Zitat Metz M, Scholz E, Ferran M, et al.: Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in acquired cold urticaria. Ann Allergy Asthma Immunol 2010, 104:86–92.CrossRefPubMed Metz M, Scholz E, Ferran M, et al.: Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in acquired cold urticaria. Ann Allergy Asthma Immunol 2010, 104:86–92.CrossRefPubMed
47.
Zurück zum Zitat Bonadonna P, Lombardi C, Senna G, et al.: Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination. J Am Acad Dermatol 2003, 49:714–716.CrossRefPubMed Bonadonna P, Lombardi C, Senna G, et al.: Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination. J Am Acad Dermatol 2003, 49:714–716.CrossRefPubMed
48.
Zurück zum Zitat Marsland AM, Beck MH: Cold urticaria responding to systemic ciclosporin. Br J Dermatol 2003, 149:214–215.CrossRefPubMed Marsland AM, Beck MH: Cold urticaria responding to systemic ciclosporin. Br J Dermatol 2003, 149:214–215.CrossRefPubMed
49.
Zurück zum Zitat Boyce JA: Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol 2006, 117:1415–1418.CrossRefPubMed Boyce JA: Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol 2006, 117:1415–1418.CrossRefPubMed
50.
Zurück zum Zitat •• Bodar EJ, Simon A, de Visser M, van der Meer JW: Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra). Neth J Med 2009, 67:302–305. The good response to anti-interleukin-1 in a case of severe CCU suggests a possible role for interleukin-1 not only in the pathogenesis of cryopyrin-associated periodic syndromes but also in CCU.PubMed •• Bodar EJ, Simon A, de Visser M, van der Meer JW: Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra). Neth J Med 2009, 67:302–305. The good response to anti-interleukin-1 in a case of severe CCU suggests a possible role for interleukin-1 not only in the pathogenesis of cryopyrin-associated periodic syndromes but also in CCU.PubMed
51.
Zurück zum Zitat Bird JA, Burks W: Peanut allergy saves a patient with cold-induced hypotension and urticaria. J Pediatr 2010, 156:687.CrossRefPubMed Bird JA, Burks W: Peanut allergy saves a patient with cold-induced hypotension and urticaria. J Pediatr 2010, 156:687.CrossRefPubMed
52.
Zurück zum Zitat Toth-Kasa I, Jancso G, Obal F Jr, et al.: Involvement of sensory nerve endings in cold and heat urticaria. J Invest Dermatol 1983, 80:34–36.CrossRefPubMed Toth-Kasa I, Jancso G, Obal F Jr, et al.: Involvement of sensory nerve endings in cold and heat urticaria. J Invest Dermatol 1983, 80:34–36.CrossRefPubMed
53.
Zurück zum Zitat Keahey TM, Indrisano J, Kaliner MA: A case study on the induction of clinical tolerance in cold urticaria. J Allergy Clin Immunol 1988, 82:256–261.CrossRefPubMed Keahey TM, Indrisano J, Kaliner MA: A case study on the induction of clinical tolerance in cold urticaria. J Allergy Clin Immunol 1988, 82:256–261.CrossRefPubMed
54.
Zurück zum Zitat von Mackensen YA, Sticherling M: Cold urticaria: tolerance induction with cold baths. Br J Dermatol 2007, 157:835–836.CrossRef von Mackensen YA, Sticherling M: Cold urticaria: tolerance induction with cold baths. Br J Dermatol 2007, 157:835–836.CrossRef
55.
Zurück zum Zitat Hoffman HM, Throne ML, Amar NJ, et al.: Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum 2008, 58:2443–2452.CrossRefPubMed Hoffman HM, Throne ML, Amar NJ, et al.: Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum 2008, 58:2443–2452.CrossRefPubMed
56.
Zurück zum Zitat Goldbach-Mansky R, Kastner DL: Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses. J Allergy Clin Immunol 2009, 124:1141–1149; quiz 1150–1151.CrossRefPubMed Goldbach-Mansky R, Kastner DL: Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses. J Allergy Clin Immunol 2009, 124:1141–1149; quiz 1150–1151.CrossRefPubMed
Metadaten
Titel
Modern Approaches to the Diagnosis and Treatment of Cold Contact Urticaria
verfasst von
Karoline Krause
Torsten Zuberbier
Marcus Maurer
Publikationsdatum
01.07.2010
Verlag
Current Science Inc.
Erschienen in
Current Allergy and Asthma Reports / Ausgabe 4/2010
Print ISSN: 1529-7322
Elektronische ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-010-0121-3

Weitere Artikel der Ausgabe 4/2010

Current Allergy and Asthma Reports 4/2010 Zur Ausgabe

Clinical Trial Report

Treatment of Cold Urticaria

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.